ArticleOncoTargets and therapy2020

Response to Anti-HER2-Based Treatment in a Patient with Bladder Adenocarcinoma Harboring

Xiaolu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.